Aspire Universal Unveils $300M Precision Medicine Fund
Lancaster, Pennsylvania-based private equity and venture capital firm Aspire Universal on Tuesday said it had launched a $300 million fund aimed at speeding up investment, testing and approval for startups and...To view the full article, register now.
Already a subscriber? Click here to view full article